Based on our ultimate spirit, GBC develops new drug candidates through our solid footstone and promotes health by promising and more effective medications for oncological, autoimmune, degenerative, metabolic and orphan diseases etc. We dedicate to advancing health and welfare in whole life.
view moreThis trial is a Phase 2 randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Antroquinonol in hospitalized patients with mild to moderate pneumonia due to COVID-19 (Coronavirus SARS-CoV-2 disease). The trial completed recruiting for 124 patients in the USA, Peru and Argentina where the new pandemic upheaval is rampant with highly transmitted SARS-CoV-2 variants.
view more